Ledger.Open graph →

SEC Form D · filed September 5, 2017

Amytrx Therapeutics, Inc

Offering

$2.1M

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

NASHVILLE, TN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Dennis J. Carlo · SAN DIEGO, CADirector Lawrence W. Greer · Nashville, TNDirector Raymond J. Pirtle · Nashville, TNDirector Matthew A. Gonda · Nashville, TNExec · Director Thomas G. Andrews · Nashville, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗